Target intelligence / Profile preview

Colon and tissue detoxification

Molecular classification
Other
01

Overview

Colon and tissue detoxification" is not a specific molecule or receptor but rather refers to the collective biological processes by which the colon—and other tissues—neutralize and eliminate toxic substances. In the colon, this involves a range of **detoxification enzymes** expressed in intestinal epithelial cells. These include phase I enzymes like cytochrome P450s that oxidize toxins; phase II conjugation enzymes; and phase III transporters for excretion[1][2]. The activity of these systems is regulated by transcription factors such as pregnane X receptor (PXR), aryl hydrocarbon receptor (AhR), and Nrf2[1]. The colon also contains specialized mechanisms for neutralizing specific toxins like hydrogen sulfide through sulfide-detoxifying enzymes; impairment in these pathways can contribute to inflammation or mucosal damage[4][5]. While "colon and tissue detoxification" describes an essential physiological function critical for maintaining gut health and systemic homeostasis, it does not correspond to a single molecular target suitable for drug development. There is something wrong with this target name because it does not refer to a discrete molecule/receptor but rather an entire physiological process involving multiple molecular players. For structured data purposes, you should instead specify individual targets such as "Pregnane X receptor," "Aryl hydrocarbon receptor," "Cytochrome P450 family," etc., depending on your focus within the broader context of tissue/colon detoxification.

02

Biological functions

DetoxificationBarrier functionMetabolism of xenobiotics and endogenous compoundsRegulation of immune response (indirectly via barrier integrity)
03

Disease associations

Inflammation (e.g., colitis)Cancer (colorectal cancer risk related to detoxification capacity)Other (general protection from toxins and xenobiotics)
04

Safety considerations

Impaired detoxification can lead to mucosal injury, inflammation, or increased disease risk[5]Modulation by food components or drugs may alter drug metabolism and side effects[1]
05

Biomarkers

Expression/activity levels of detoxification enzymes such as cytochrome P450s, glutamine synthetase, glutamate dehydrogenase, sulfide-detoxifying enzymes[1][3][5]

Beyond the preview

Go deeper on Colon and tissue detoxification.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colon and tissue detoxification.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call